Inhibiting IQGAP1 reduced anchorage-independent growth, migration, and invasion of MCF7 breast cancer cells in vitro, and tumor growth and vascularization of MCF7 xenografts in vivo [8,38]. Here, IQGAP1 is linked to breast carcinoma.